Klaus Pantel

81.7k total citations · 25 hit papers
721 papers, 54.1k citations indexed

About

Klaus Pantel is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Klaus Pantel has authored 721 papers receiving a total of 54.1k indexed citations (citations by other indexed papers that have themselves been cited), including 483 papers in Oncology, 373 papers in Cancer Research and 222 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Klaus Pantel's work include Cancer Cells and Metastasis (371 papers), Cancer Genomics and Diagnostics (285 papers) and Prostate Cancer Treatment and Research (55 papers). Klaus Pantel is often cited by papers focused on Cancer Cells and Metastasis (371 papers), Cancer Genomics and Diagnostics (285 papers) and Prostate Cancer Treatment and Research (55 papers). Klaus Pantel collaborates with scholars based in Germany, United States and France. Klaus Pantel's co-authors include Catherine Alix‐Panabières, Heidi Schwarzenbach, Sabine Riethdorf, Ruud H. Brakenhoff, Volkmar Müller, Dave S.�B. Hoon, Harriet Wikman, Wolfgang Janni, Yibin Kang and Stephan Braun and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Klaus Pantel

695 papers receiving 53.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-free nucleic acids as biomarkers in cancer patients

2011 2.2k citations Heidi Schwarzenbach, Klaus Pantel et al. profile →
Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

2007 1.1k citations Sabine Riethdorf, Volkmar Müller et al. Clinical Cancer Research profile →
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

2014 1.1k citations Harriet Wikman, Klaus Pantel et al. profile →
Dissecting the metastatic cascade

2004 1.0k citations Klaus Pantel, Ruud H. Brakenhoff profile →
Challenges in circulating tumour cell research

2014 1.0k citations Catherine Alix‐Panabières, Klaus Pantel profile →
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

2016 1.0k citations Catherine Alix‐Panabières, Klaus Pantel Cancer Discovery profile →
Detection, clinical relevance and specific biological properties of disseminating tumour cells

2008 930 citations Klaus Pantel, Ruud H. Brakenhoff et al. profile →
Circulating Tumor Cells: Liquid Biopsy of Cancer

2012 899 citations Catherine Alix‐Panabières, Klaus Pantel profile →
Clinical relevance of circulating cell-free microRNAs in cancer

2014 862 citations Heidi Schwarzenbach, Klaus Pantel et al. profile →
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

2013 836 citations Andreas Schneeweiß, Sabine Riethdorf et al. profile →
In vitro differentiation of endothelial cells from AC133-positive progenitor cells

2000 795 citations Klaus Pantel, Gunter Schuch et al. profile →
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer

2000 726 citations Stephan Braun, Klaus Pantel et al. profile →
Liquid biopsy and minimal residual disease — latest advances and implications for cure

2019 721 citations Klaus Pantel, Catherine Alix‐Panabières profile →
Tumor metastasis: moving new biological insights into the clinic

2013 620 citations Klaus Pantel et al. profile →
Circulating tumour cells in cancer patients: challenges and perspectives

2010 610 citations Klaus Pantel, Catherine Alix‐Panabières profile →
Cancer micrometastases

2009 517 citations Klaus Pantel, Catherine Alix‐Panabières et al. profile →
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

2014 472 citations Brigitte Rack, Julia Jückstöck et al. profile →
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape

2016 462 citations Sabine Riethdorf, Klaus Pantel et al. profile →
Biology, detection, and clinical implications of circulating tumor cells

2014 422 citations Simon A. Joosse, Tobias M. Gorges et al. profile →
The biology of circulating tumor cells

2015 410 citations Klaus Pantel, Michael R. Speicher profile →
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells

2019 405 citations Klaus Pantel et al. profile →
VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors

2011 397 citations Sabine Riethdorf, Klaus Pantel et al. profile →
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

2022 355 citations François‐Clément Bidard, Klaus Pantel et al. profile →
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond

2020 274 citations Harriet Wikman, Klaus Pantel et al. profile →
Circulating tumour cells for early detection of clinically relevant cancer

2023 205 citations Klaus Pantel et al. profile →

Peers

Countries citing papers authored by Klaus Pantel

Since Specialization

Citations

This map shows the geographic impact of Klaus Pantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Pantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Pantel more than expected).

Fields of papers citing papers by Klaus Pantel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Pantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Pantel. The network helps show where Klaus Pantel may publish in the future.

Co-authorship network of co-authors of Klaus Pantel

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Pantel. A scholar is included among the top collaborators of Klaus Pantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Pantel. Klaus Pantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	KRAS and GNAS mutations in cell-free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms – an observational pilot study 2024 ·Pancreatology ·Christine Nitschke, (unknown), Walter Philipp, K. Meißner, (unknown), (unknown), Andreas W. Berger, Jakob R. Izbicki, Felix Nickel, Thilo Hackert, Klaus Pantel, Harriet Wikman, Faik G. Uzunoǧlu	0
2	Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett’s carcinoma 2021 ·Gut ·Hanno Ehlken, Rüdiger Schmitz, Sabine Riethdorf, Lutz Riethdorf, Jenny Krause, (unknown), Jörg Schrader, (unknown), Anastasios D. Giannou, William Sterlacci, Michael Vieth, Till S. Clauditz, Christian M. Kähler, Oliver Mann, Jakob R. Izbicki, Samuel Huber, Klaus Pantel, Thomas Rösch	1
3	Blockade of Myeloid-Derived Suppressor Cell Expansion with All- Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy 2018 ·Cancer Research ·(unknown), (unknown), Mark Wroblewski, Isabel Ben‐Batalla, Ines Miranda Santos, Federico Taverna, (unknown), (unknown), (unknown), Stefan Vinckier, Johanna M. Brandner, Klaus Pantel, Carsten Bokemeyer, Thomas Vogl, Johannes Roth, Peter Carmeliet, Sonja Loges	97
4	miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis–Associated Genes 2018 ·Cancer Research ·Martine Croset, Francesco Pantano, Casina W.S. Kan, Edith Bonnelye, Françoise Descôtes, Catherine Alix‐Panabières, Charles‐Henri Lecellier, Richard Bachelier, Nathalie Allioli, Saw-See Hong, Kai Bartkowiak, Klaus Pantel, Philippe Clézardin	150
5	Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy breakdown → 2016 ·Cancer Discovery ·Catherine Alix‐Panabières, Klaus Pantel	1020
6	Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer 2016 ·Clinical Cancer Research ·Wolfgang Janni, Brigitte Rack, Leon W.M.M. Terstappen, Jean‐Yves Pierga, Florin‐Andrei Taran, Tanja Fehm, Carolyn Hall, Marco R. de Groot, François‐Clément Bidard, Thomas W. P. Friedl, Peter A. Fasching, Sara Y. Brucker, Klaus Pantel, Anthony Lucci	265
7	Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells 2015 ·Clinical Cancer Research ·Tobias M. Gorges, (unknown), (unknown), Simon A. Joosse, Sabine Riethdorf, (unknown), Klaus Lücke, Harriet Wikman, Stephen M. Jackson, (unknown), Oliver von Ahsen, Christian Schumann, Thomas Krahn, Klaus Pantel	129
8	Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response 2015 ·Cancer Research ·Kai Bartkowiak, Marcel Kwiatkowski, Friedrich Buck, Tobias M. Gorges, Lars Nilse, Volker Assmann, Antje Andreas, Volkmar Müller, Harriet Wikman, Sabine Riethdorf, Hartmut Schlüter, Klaus Pantel	65
9	Circulating Tumor Cells in Patients with Testicular Germ Cell Tumors 2014 ·Clinical Cancer Research ·Paulina Nastały, Christian Ruf, (unknown), Natalia Bednarz‐Knoll, (unknown), Refik Kavsur, Hendrik Isbarn, Cord Matthies, Walter Wagner, (unknown), Margit Fisch, Carsten Bokemeyer, Sascha Ahyai, Friedemann Honecker, Sabine Riethdorf, Klaus Pantel	41
10	Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of Patients with Squamous Cell Carcinoma of the Oral Cavity 2013 ·Clinical Cancer Research ·Alexander Gröbe, Marco Blessmann, Henning Hanken, Reinhard E. Friedrich, Gerhard Schön, Johannes Wikner, Katharina E. Effenberger, Lan Kluwe, Max Heiland, Klaus Pantel, Sabine Riethdorf	111
11	Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing 2013 ·Cancer Research ·Ellen Heitzer, Martina Auer, Christin Gasch, Martin Pichler, Peter Ulz, Eva Maria Hoffmann, Sigurd Lax, Julie Waldispuehl‐Geigl, Oliver Mauermann, Carolin Lackner, Gerald Höfler, Florian Eisner, Heinz Sill, Hellmut Samonigg, Klaus Pantel, Sabine Riethdorf, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher	403
12	Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer 2012 ·Clinical Cancer Research ·Dharanija Madhavan, Manuela Zucknick, Markus Wallwiener, Katarina Ćuk, (unknown), Martina Scharpff, Sarah Schott, Jörg Heil, Andrey Turchinovich, Rongxi Yang, Axel Benner, Sabine Riethdorf, Andreas Trumpp, Christof Sohn, Klaus Pantel, Andreas Schneeweiß, Barbara Burwinkel	214
13	Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells 2012 ·Clinical Cancer Research ·Simon A. Joosse, Juliane Hannemann, (unknown), Andreas Bauche, Antje Andreas, Volkmar Müller, Klaus Pantel	126
14	Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation 2012 ·Cancer Research ·Steven R. Barthel, (unknown), (unknown), Matthew Opperman, Kempland C. Walley, Leonardo Nimrichter, Monica M. Burdick, Bryan M. Gillard, Michael T. Moser, Klaus Pantel, Barbara A. Foster, Kenneth J. Pienta, Charles J. Dimitroff	60
15	Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression 2012 ·Clinical Cancer Research ·Heidi Schwarzenbach, Corinna Eichelser, (unknown), Wolfgang Janni, Brigitte Rack, Klaus Pantel	50
16	Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis 2011 ·Clinical Cancer Research ·Wolfgang Janni, Florian D. Vogl, Gro Wiedswang, Marit Synnestvedt, Tanja Fehm, Julia Jückstöck, Elin Borgen, Brigitte Rack, Stephan Braun, Harald Sommer, Erich Solomayer, Klaus Pantel, Jahn M. Nesland, Klaus Friese, Bjørn Naume	192
17	BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral Blood 2010 ·Clinical Cancer Research ·Natalia Bednarz‐Knoll, Elke Eltze, Axel Semjonow, Michael Rink, Antje Andreas, Lennart Mulder, Juliane Hannemann, Margit Fisch, Klaus Pantel, Heinz‐Ulrich G. Weier, Krzysztof Piotr Bielawski, Burkhard Brandt	53
18	Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion 2009 ·Clinical Cancer Research ·(unknown), Salla Ruosaari, Paul P. Eijk, Jussuf T. Kaifi, Jaakko Hollmén, Emre F. Yekebas, Jakob R. Izbicki, Ruud H. Brakenhoff, Thomas Streichert, Sabine Riethdorf, Markus Glatzel, Bauke Ylstra, Klaus Pantel, Harriet Wikman	72
19	Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment 2008 ·Journal of Clinical Oncology ·Jens Köllermann, Steffen Weikert, Martin Schostak, Carsten Kempkensteffen, K. Kleinschmidt, Thomas Rau, Klaus Pantel	62
20	Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis 2007 ·Clinical Cancer Research ·Sonja Loges, (unknown), Uta Reichelt, Michaël Bubenheim, Andreas Erbersdobler, Paulus Schurr, Emre F. Yekebas, Gunter Schuch, Jakob R. Izbicki, Klaus Pantel, Carsten Bokemeyer, Walter Fiedler	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact